Last reviewed · How we verify

NCT04079205

Home Rehabilitation Using Smart Wearable Exercise and Electrical Stimulation Device After Anterior Cruciate Ligament Reconstruction

Terminated NA Last updated 27 September 2021
What this trial tests

NA trial testing Wearable Device(exoRehab) in Anterior Cruciate Ligament Reconstruction in 10 participants. Terminated before completion.

Timeline
31 December 2018
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorSeoul National University Bundang Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment10
Start date31 December 2018
Primary completion30 June 2021
Estimated completion30 June 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Bundang Hospital

Who can join

19 and older, any sex, with Anterior Cruciate Ligament Reconstruction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop and apply a rehabilitation program for patients who are discharged after ACL reconstruction using a wearable joint rehabilitation exercise device (exoRehab).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Home-based rehabilitation using smart wearable knee exercise device with electrical stimulation after anterior cruciate ligament reconstruction: A study protocol for a randomized controlled trial.
    Kim G, Kim WS, Kim TW, Lee YS, et al · · 2020 · cited 4× · PMID 32443364 · DOI 10.1097/md.0000000000020256

Verify or expand the search:

Other recruiting trials for Anterior Cruciate Ligament Reconstruction

Currently open trials in the same condition.

Other Seoul National University Bundang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04079205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing